| MA | Moyamoya angiopathy |
| cEPCs | Circulating endothelial progenitor cells |
| HD | Healthy donors |
| ICAs | Internal carotid arteries |
| RNF213 | Ring Finger Protein 213 |
| PBMCs | Peripheral blood mononuclear cells |
| TIA | Transient ischemic attack |
| ACVD | Atherosclerotic cerebrovascular disease |
| WB | White blood |
| SD vWF VEGF-R2 |
Standard deviation von Willebrand Factor Vascular endothelial growth factor receptor-2 |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| EGM-MV | Microvascular Endothelial Cell Growth Medium |
| HGF | Hepatocyte growth factor |
| TGF-β1 CCL5 CCL2 |
Transforming growth factor-beta 1 Chemokine (C-C motif) ligand 5 Chemokine (C-C motif) ligand 2 |
| β2M | Beta 2-microglobulin |
| EDTA | Ethylenediaminetetraacetic acid |
| EBM | Endothelial Basal Medium |
| n | Number |
| A | Adult |
| P | Pediatric |
| FACS | Fluorescence-activated cell sorting |
| na | Not available |
| ECFCs CECs |
Endothelial colony forming cells Circulating endothelial cells |
| AA | Alcohol abuse |
| AD | Antidepressant |
| AE | Antiepileptic |
| AH | Antihypertensive |
| AHHC | Anti-hyperhomocysteinemia |
| AG | Antiaggregants |
| B | Bilateral |
| CCB | Calcium channel blockers |
| CVD | Cerebrovascular disease |
| DL | Dyslipidemia |
| DM | Diabetes mellitus |
| ET | Estroprogestinic therapy |
| f | Female |
| H | Hypertension |
| HHC | Hyperhomocysteinemia |
| HoS | History of smoking |
| HS | Hemorrhagic stroke |
| HT | Head trauma |
| IHH | Ischemic heart disease |
| IS | Ischemic stroke |
| m | Male |
| NIHSS | National Institute of Health Scale |
| PI | Physical inactivity |
| PSY | psychiatric disorder |
| ST | Statins |
| U | Unilateral |